Sunny Leone’s Bengaluru show passes off peacefully as Kannada outfit backs off

Mangaluru, Feb 11: Renowned journalist and winner of Magsaysay award, P Sainath will be in Mangaluru on February 14 & 15 at St. Aloysius College (Autonomous). He will speak on the topic ‘Indian democracy in post liberalisation and post truth era’.

P Sainath’s two-day visit to St. Aloysius College will also feature a workshop by the veteran journalist on his rural development project PARI (People’s Archives of Rural India). It is a part of the tenth edition of Media Manthan, a National level media fest organised by the post-graduate department of Journalism and Mass Communication of St. Aloysius College.

P. Sainath is a veteran journalist and media activist who has an avid interest in rural reporting. People’s Archives of Rural India (PARI), a digital journalism platform is an initiative put forward by him which aims to document rural Indian lives and livelihood. Sainath is also a teacher who has trained over 1000 media persons across 27 years.

Media Manthan is a media festival by the PG Department of Mass Communication of St. Aloysius College (Autonomous). Besides endowment lecture and workshop by P. Sainath, the fest holds various media-related competitions for the students of various colleges from across the state.

Dammam: President of Indian Social Forum, Eastern Province Mr.Wasim Rabbani urged immediate intervention of Indian government to help Non Residential Indians who are in trouble due to corona pandemic in Saudi Arabia.

He said in a press rease that expatriate Indians are in concern  as number of corona infected people and  deaths are increasing in danger level.

Hea said, "the Saudi health minister's statement a few days ago indicates that the situation in Saudi needs to be taken more seriously with precautionary methods. There are concerns among expatriates because the number of people infected with the coronavirus and the number of deaths reported in various provinces are increasing at an alarming rate."

"Saudi Government and Health Ministry are taking excellent precautionary measures, however, in the coming days expect to see the number of cases to increase in Saudi Arabia. The Indian government needs to take diplomatic and immediate intervention to ensure the treatment of Indian expatriates considering the number of effected people increasing", He said.

He also urged that the Embassy and the Government of India should ensure qaurantiane faculty for Indian expatriates and arrange special low cost flights to bring back expatriates who would like to return home country.

" Government of India and Indian embassy need to intervene immediately to ensure that the quarantine system is in place for Indian expatriates as the facilities in the rooms where the residents are staying together are very limited. There should also be a mechanism to organize low-cost flight services for expatriates who are ready to go home. The government system should also be able to accommodate the expatriates in special quarantine areas in hometown as soon they arrive in India", he urged.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.